MELSMON 2ml 10amp.
128 $
Find the best price
Dosage form
- Solution for subcutaneous injection: 2 ml ampoules.
- Packaging: 10 ampoules.
Please note that the appearance of the packaging may vary depending on the manufacturer and region of sale.
Active ingredient
Human placenta hydrolysate: 100 mg in 2 ml solution.
Dosage
- Recommended dose for adults: 2 ml (1 ampoule) every other day (3 ampoules per week) for 2 weeks.
- If necessary, the course can be repeated after 1-2 weeks.
- Method of administration: only subcutaneously; intravenous administration is strictly prohibited.
Melsmon is a preparation containing a hydrolysate of human placenta, used to address asthenic conditions in peri- and postmenopausal women.
Indications for Use:
- Asthenic Conditions:
- For peri- and postmenopausal women experiencing symptoms such as decreased attention, reduced performance, excessive excitability, and heightened reactivity.
Contraindications:
- Known hypersensitivity to any components of the drug.
- Disorders of the endocrine glands.
- Arterial hypertension.
- Pregnancy and breastfeeding.
- Use in children.
Side Effects:
- Allergic Reactions:
- Rash, pruritus (itching), dermatitis, urticaria (hives).
- Fever, chills, nausea.
- Local Reactions:
- Pain, redness, or a sensation of warmth at the injection site.
- Other:
- Pain or tenderness in the mammary glands.
Special Instructions:
- Medical Supervision:
- Treatment with Melsmon should be conducted under the supervision of a healthcare professional.
- Routine Medical Examination:
- Peri- and postmenopausal women are advised to undergo a medical check-up at least once every six months during treatment.
- Effect on Driving and Machinery Operation:
- The drug does not impair the ability to drive vehicles or operate machinery.
- Consultation Recommended:
- Prior to starting treatment with Melsmon, consult a healthcare provider to determine the suitability of therapy and establish the correct dosage. Self-medication is strongly discouraged and may lead to adverse effects.
